HomeBiogas Ltd (TLV: HMGS)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
92.90
-0.50 (-0.54%)
Oct 15, 2024, 5:24 PM IDT

HomeBiogas Statistics

Total Valuation

HomeBiogas has a market cap or net worth of ILS 22.34 million. The enterprise value is 10.67 million.

Market Cap 22.34M
Enterprise Value 10.67M

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date Nov 14, 2024
Ex-Dividend Date n/a

Share Statistics

HomeBiogas has 24.05 million shares outstanding. The number of shares has increased by 17.69% in one year.

Shares Outstanding 24.05M
Shares Change (YoY) +17.69%
Shares Change (QoQ) -0.32%
Owned by Insiders (%) 9.52%
Owned by Institutions (%) 16.20%
Float 10.89M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.00
PB Ratio 0.60
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.28
EV / Sales 0.96
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -0.31

Financial Position

The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.16.

Current Ratio 2.99
Quick Ratio 2.36
Debt / Equity 0.16
Debt / EBITDA n/a
Debt / FCF -0.18
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -69.30% and return on invested capital (ROIC) is -38.88%.

Return on Equity (ROE) -69.30%
Return on Assets (ROA) -32.65%
Return on Capital (ROIC) -38.88%
Revenue Per Employee 161,736
Profits Per Employee -547,522
Employee Count 69
Asset Turnover 0.16
Inventory Turnover 1.64

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -74.71% in the last 52 weeks. The beta is 0.02, so HomeBiogas's price volatility has been lower than the market average.

Beta (5Y) 0.02
52-Week Price Change -74.71%
50-Day Moving Average 110.29
200-Day Moving Average 263.12
Relative Strength Index (RSI) 8.76
Average Volume (20 Days) 9,025

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HomeBiogas had revenue of ILS 11.16 million and -37.78 million in losses. Loss per share was -1.58.

Revenue 11.16M
Gross Profit 1.95M
Operating Income -37.45M
Pretax Income -37.76M
Net Income -37.78M
EBITDA -36.03M
EBIT -37.45M
Loss Per Share -1.58
Full Income Statement

Balance Sheet

The company has 17.70 million in cash and 6.03 million in debt, giving a net cash position of 11.67 million or 0.49 per share.

Cash & Cash Equivalents 17.70M
Total Debt 6.03M
Net Cash 11.67M
Net Cash Per Share 0.49
Equity (Book Value) 37.26M
Book Value Per Share 1.55
Working Capital 23.08M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -32.12 million and capital expenditures -2.20 million, giving a free cash flow of -34.33 million.

Operating Cash Flow -32.12M
Capital Expenditures -2.20M
Free Cash Flow -34.33M
FCF Per Share -1.43
Full Cash Flow Statement

Margins

Gross Margin 17.48%
Operating Margin -335.59%
Pretax Margin -338.39%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -307.59%

Dividends & Yields

HomeBiogas does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -17.69%
Shareholder Yield -17.69%
Earnings Yield n/a
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HomeBiogas has an Altman Z-Score of -4.03. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.03
Piotroski F-Score n/a